世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039677

乗り物酔い薬の世界市場(2024-2028)

TechNavio

Global motion sickness drugs market 2024-2028

発刊日 2024/06/13

言語英語

体裁PDF/169ページ

ライセンス/価格169ページ

0000039677

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

乗り物酔い薬市場は、2023年から2028年に1億3,950万米ドルの成長し、予測期間中のCAGRは4.37%で加速すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。この市場は、市販薬(OTC)の入手可能性、乗り物酔い薬の複数の剤形が入手可能であること、そして世界的に旅行や観光が増加することによって推進されています。

調査範囲

  • 市場セグメント
    ➣ 製品別
      ◇ 抗ヒスタミン薬
      ◇ 抗コリン薬
    ➣ 流通チャネル別
      ◇ オフライン
      ◇ オンライン
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

この調査では、今後数年間の乗り物酔い薬市場の成長を牽引する主な理由の 1 つとして、吐き気を催す情報技術の出現が挙げられています。また、オンラインチャネルの浸透の増加と心身症に関する研究の増加により、市場で大きな需要が生まれるでしょう。

乗り物酔い薬市場に関するレポートは、次の分野をカバーしています。

  • 乗り物酔い薬市場の規模
  • 乗り物酔い薬市場の予測
  • 乗り物酔い薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ Amneal Pharmaceuticals Inc.
    ➣ Baxter International Inc.
    ➣ CVS Health Corp.
    ➣ DM Pharma Marketing Pvt. Ltd.
    ➣ GlaxoSmithKline Plc
    ➣ Hylands
    ➣ Lupin Ltd
    ➣ Merck KGaA
    ➣ Myungmoon Pharm Co. Ltd.
    ➣ Novartis AG
    ➣ Perrigo Co. Plc
    ➣ Prestige Consumer Healthcare Inc.
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Tivic Health Systems Inc.
    ➣ Viatris Inc.
    ➣ WellSpring Pharmaceutical Corp.
    ➣ Zenomed Healthcare Pvt. Ltd.
    ➣ Zydus Lifesciences Ltd.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Motion Sickness Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Motion Sickness Drugs Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Antihistamines - Market size and forecast 2023-2028
Chart on Antihistamines - Market size and forecast 2023-2028 ($ million)
Data Table on Antihistamines - Market size and forecast 2023-2028 ($ million)
Chart on Antihistamines - Year-over-year growth 2023-2028 (%)
Data Table on Antihistamines - Year-over-year growth 2023-2028 (%)
6.4 Anticholinergics - Market size and forecast 2023-2028
Chart on Anticholinergics - Market size and forecast 2023-2028 ($ million)
Data Table on Anticholinergics - Market size and forecast 2023-2028 ($ million)
Chart on Anticholinergics - Year-over-year growth 2023-2028 (%)
Data Table on Anticholinergics - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
Chart on Offline - Market size and forecast 2023-2028 ($ million)
Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Chart on Offline - Year-over-year growth 2023-2028 (%)
Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ million)
Data Table on Online - Market size and forecast 2023-2028 ($ million)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc. - Overview
Amneal Pharmaceuticals Inc. - Business segments
Amneal Pharmaceuticals Inc. - Key news
Amneal Pharmaceuticals Inc. - Key offerings
Amneal Pharmaceuticals Inc. - Segment focus
12.5 Baxter International Inc.
Baxter International Inc. - Overview
Baxter International Inc. - Business segments
Baxter International Inc. - Key news
Baxter International Inc. - Key offerings
Baxter International Inc. - Segment focus
12.6 CVS Health Corp.
CVS Health Corp. - Overview
CVS Health Corp. - Business segments
CVS Health Corp. - Key offerings
CVS Health Corp. - Segment focus
12.7 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.8 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.9 Myungmoon Pharm Co. Ltd.
Myungmoon Pharm Co. Ltd. - Overview
Myungmoon Pharm Co. Ltd. - Product / Service
Myungmoon Pharm Co. Ltd. - Key offerings
12.10 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.11 Perrigo Co. Plc
Perrigo Co. Plc - Overview
Perrigo Co. Plc - Business segments
Perrigo Co. Plc - Key offerings
Perrigo Co. Plc - Segment focus
12.12 Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. - Overview
Prestige Consumer Healthcare Inc. - Business segments
Prestige Consumer Healthcare Inc. - Key offerings
Prestige Consumer Healthcare Inc. - Segment focus
12.13 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
12.14 Tivic Health Systems Inc.
Tivic Health Systems Inc. - Overview
Tivic Health Systems Inc. - Product / Service
Tivic Health Systems Inc. - Key offerings
12.15 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
12.16 WellSpring Pharmaceutical Corp.
WellSpring Pharmaceutical Corp. - Overview
WellSpring Pharmaceutical Corp. - Product / Service
WellSpring Pharmaceutical Corp. - Key offerings
12.17 Zydus Lifesciences Ltd.
Zydus Lifesciences Ltd. - Overview
Zydus Lifesciences Ltd. - Business segments
Zydus Lifesciences Ltd. - Key news
Zydus Lifesciences Ltd. - Key offerings
Zydus Lifesciences Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Motion Sickness Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Product - Market share 2023-2028 (%)
Exhibits33: Data Table on Product - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Product
Exhibits35: Data Table on Comparison by Product
Exhibits36: Chart on Antihistamines - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Antihistamines - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Antihistamines - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Antihistamines - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Anticholinergics - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Anticholinergics - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Anticholinergics - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Anticholinergics - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Product ($ million)
Exhibits45: Data Table on Market opportunity by Product ($ million)
Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Distribution Channel
Exhibits49: Data Table on Comparison by Distribution Channel
Exhibits50: Chart on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by Distribution Channel ($ million)
Exhibits59: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2023-2028 (%)
Exhibits62: Data Table on Market share by geography 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Data Tables on Market opportunity by geography ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: Abbott Laboratories - Overview
Exhibits110: Abbott Laboratories - Business segments
Exhibits111: Abbott Laboratories - Key news
Exhibits112: Abbott Laboratories - Key offerings
Exhibits113: Abbott Laboratories - Segment focus
Exhibits114: Amneal Pharmaceuticals Inc. - Overview
Exhibits115: Amneal Pharmaceuticals Inc. - Business segments
Exhibits116: Amneal Pharmaceuticals Inc. - Key news
Exhibits117: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits118: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits119: Baxter International Inc. - Overview
Exhibits120: Baxter International Inc. - Business segments
Exhibits121: Baxter International Inc. - Key news
Exhibits122: Baxter International Inc. - Key offerings
Exhibits123: Baxter International Inc. - Segment focus
Exhibits124: CVS Health Corp. - Overview
Exhibits125: CVS Health Corp. - Business segments
Exhibits126: CVS Health Corp. - Key offerings
Exhibits127: CVS Health Corp. - Segment focus
Exhibits128: GlaxoSmithKline Plc - Overview
Exhibits129: GlaxoSmithKline Plc - Business segments
Exhibits130: GlaxoSmithKline Plc - Key news
Exhibits131: GlaxoSmithKline Plc - Key offerings
Exhibits132: GlaxoSmithKline Plc - Segment focus
Exhibits133: Lupin Ltd. - Overview
Exhibits134: Lupin Ltd. - Product / Service
Exhibits135: Lupin Ltd. - Key news
Exhibits136: Lupin Ltd. - Key offerings
Exhibits137: Myungmoon Pharm Co. Ltd. - Overview
Exhibits138: Myungmoon Pharm Co. Ltd. - Product / Service
Exhibits139: Myungmoon Pharm Co. Ltd. - Key offerings
Exhibits140: Novartis AG - Overview
Exhibits141: Novartis AG - Business segments
Exhibits142: Novartis AG - Key news
Exhibits143: Novartis AG - Key offerings
Exhibits144: Novartis AG - Segment focus
Exhibits145: Perrigo Co. Plc - Overview
Exhibits146: Perrigo Co. Plc - Business segments
Exhibits147: Perrigo Co. Plc - Key offerings
Exhibits148: Perrigo Co. Plc - Segment focus
Exhibits149: Prestige Consumer Healthcare Inc. - Overview
Exhibits150: Prestige Consumer Healthcare Inc. - Business segments
Exhibits151: Prestige Consumer Healthcare Inc. - Key offerings
Exhibits152: Prestige Consumer Healthcare Inc. - Segment focus
Exhibits153: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits154: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits155: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits156: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits157: Tivic Health Systems Inc. - Overview
Exhibits158: Tivic Health Systems Inc. - Product / Service
Exhibits159: Tivic Health Systems Inc. - Key offerings
Exhibits160: Viatris Inc. - Overview
Exhibits161: Viatris Inc. - Business segments
Exhibits162: Viatris Inc. - Key news
Exhibits163: Viatris Inc. - Key offerings
Exhibits164: Viatris Inc. - Segment focus
Exhibits165: WellSpring Pharmaceutical Corp. - Overview
Exhibits166: WellSpring Pharmaceutical Corp. - Product / Service
Exhibits167: WellSpring Pharmaceutical Corp. - Key offerings
Exhibits168: Zydus Lifesciences Ltd. - Overview
Exhibits169: Zydus Lifesciences Ltd. - Business segments
Exhibits170: Zydus Lifesciences Ltd. - Key news
Exhibits171: Zydus Lifesciences Ltd. - Key offerings
Exhibits172: Zydus Lifesciences Ltd. - Segment focus
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Information sources
Exhibits178: Data validation
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Data synthesis
Exhibits181: 360 degree market analysis
Exhibits182: List of abbreviations

この商品のレポートナンバー

0000039677

TOP